Bid Publish Date
15-May-2025, 10:56 am
Bid End Date
05-Jun-2025, 11:00 am
Location
Progress
Quantity
4374
Indian Air Force has released a public tender for Syrup or Suspension, Injection, Tablet, Cream, Nasal Spray, Syrup, Capsule in WEST DELHI, DELHI. Quantity: 4374. Submission Deadline: 05-06-2025 11: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Item Category
Syrup or Suspension , Injection , Tablet , Cream , Nasal Spray , Syrup , Capsule
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Syrup or Suspension
Syrup Fexofenadine 30 mg per 5 ml bott of 60 ml
Injection
Inj Pheniramine Maleate 22.75 mg per ml 2 ml amp
Injection
Inj Nor Adrenaline 2 mg per ml 2 ml Inj
Tablet
Tab Topiramate 100 mg
Tablet
Tab Methotrexate 2.5 mg
Tablet
Tab Enalapril Maleate 2.5 mg
Cream
Cream Mometasone 0.1 Percentage tube of 10 gm
Tablet
Tab Frusemide 40 mg
Nasal Spray
Midazolam Nasal Spray 0.5 mg 5 ml bott
Syrup
Syrup Azithromycin 200 mg per 15 ml
Tablet
Tab Sulfasalazine 1 gm
Injection
Inj Amoxycillin 1 gm plus Clavulanic acid 200 mg 1.2 gm vial
Capsule
Cap Doxycycline 100 mg
Tablet
Tab Nitrofurantoin 100 mg
Tablet
Tab Prednisolone 10 mg
Syrup
Syrup Multivitamin 20 ml
Syrup
Syrup Mefanamic Acid plus Paracetamol 60 ml Bott
Syrup
Syrup Montelukast plus levocetrizine 60 ml
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Syrup or Suspension | Syrup Fexofenadine 30 mg per 5 ml bott of 60 ml | 120 | bottle of 60 ml | smcraj25 | 10 | |
| 2 | Injection | Inj Pheniramine Maleate 22.75 mg per ml 2 ml amp | 90 | ampoule | smcraj25 | 10 | |
| 3 | Injection | Inj Nor Adrenaline 2 mg per ml 2 ml Inj | 12 | ampoule | smcraj25 | 10 | |
| 4 | Tablet | Tab Topiramate 100 mg | 200 | number | smcraj25 | 10 | |
| 5 | Tablet | Tab Methotrexate 2.5 mg | 180 | number | smcraj25 | 10 | |
| 6 | Tablet | Tab Enalapril Maleate 2.5 mg | 300 | number | smcraj25 | 10 | |
| 7 | Cream | Cream Mometasone 0.1 Percentage tube of 10 gm | 200 | tube | smcraj25 | 10 | |
| 8 | Tablet | Tab Frusemide 40 mg | 600 | number | smcraj25 | 10 | |
| 9 | Nasal Spray | Midazolam Nasal Spray 0.5 mg 5 ml bott | 12 | bottle | smcraj25 | 10 | |
| 10 | Syrup | Syrup Azithromycin 200 mg per 15 ml | 200 | bottle | smcraj25 | 10 | |
| 11 | Tablet | Tab Sulfasalazine 1 gm | 300 | number | smcraj25 | 10 | |
| 12 | Injection | Inj Amoxycillin 1 gm plus Clavulanic acid 200 mg 1.2 gm vial | 60 | vial | smcraj25 | 10 | |
| 13 | Capsule | Cap Doxycycline 100 mg | 600 | number | smcraj25 | 10 | |
| 14 | Tablet | Tab Nitrofurantoin 100 mg | 600 | number | smcraj25 | 10 | |
| 15 | Tablet | Tab Prednisolone 10 mg | 300 | number | smcraj25 | 10 | |
| 16 | Syrup | Syrup Multivitamin 20 ml | 200 | bottle | smcraj25 | 10 | |
| 17 | Syrup | Syrup Mefanamic Acid plus Paracetamol 60 ml Bott | 200 | bottle | smcraj25 | 10 | |
| 18 | Syrup | Syrup Montelukast plus levocetrizine 60 ml | 200 | bottle | smcraj25 | 10 |
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | B LAL & SONS Under PMA | - | 31-05-2025 19:26:56 | |
| 2 | SUNIL PHARMACY Under PMA | - | 05-06-2025 10:18:52 | |
| 3 | TOTOMED INTERNATIONAL PRIVATE LIMITED Under PMA | - | 16-05-2025 13:35:25 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | B LAL & SONS(MSE)( MSE Social Category:General ) Under PMA | Item Categories : Syrup or Suspension,Injection,Injection,Tablet,Tablet,Tablet,Cream,Tablet,Nasal Spray,Syrup,Tablet, | |
| L2 | TOTOMED INTERNATIONAL PRIVATE LIMITED (MSE)( MSE Social Category:General ) Under PMA | Item Categories : Syrup or Suspension,Injection,Injection,Tablet,Tablet,Tablet,Cream,Tablet,Nasal Spray,Syrup,Tablet, |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity in the pharmaceutical sector, possessing valid licenses to operate, and ensuring compliance with government regulations. Bidders must also demonstrate their experience in delivering similar products and must meet quality standards established by health authorities.
Bidders must comply with strict technical specifications for the medicines they propose, including evidence of safety, efficacy, and quality. All products must be manufactured according to regulatory standards and require detailed documentation regarding their composition and manufacturing process.
The financial requirements involve submitting a detailed financial proposal that outlines pricing structures, payment terms, and any potential discounts. Bidders will also need to present proof of financial stability and capability to fulfill large orders, ensuring they can manage the contract's financial obligations.
Documents must be submitted electronically through the designated tender portal. Bidders are required to prepare a complete set of documents, including the tender submission form, technical and financial proposals, and all mandatory certifications. Adherence to submission guidelines is crucial for consideration.
Yes, there are special provisions aimed at supporting Micro, Small, and Medium Enterprises (MSEs) in this tender process. These benefits may include preferential treatment during the evaluation process, capacity-building initiatives, and support for startups aligning with government policies aimed at uplifting smaller businesses within the pharmaceutical industry.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS